|
|
Previous Article | Table of Contents | Next Article 
Blood, 1 February 2002, Vol. 99, No. 3, pp. 785-791
CHEMOKINES
Pathways for internalization and recycling of the chemokine
receptor CCR5
Anja Mueller,
Eamonn Kelly, and
Philip G. Strange
From the School of Animal and Microbial Sciences,
University of Reading, United Kingdom, and the Department of
Pharmacology, The Medical School, Bristol, United Kingdom.
M-tropic human immunodeficiency virus (HIV-1) strains enter the
cell after interaction with their receptors, CD4 and the
G-protein-coupled chemokine receptor CCR5. The number of cell surface
CCR5 molecules is thought to be important in determining the infection
rate for HIV. Cell surface CCR5 is dependent on the rate of receptor
internalization and recycling. Internalization of G-protein-coupled
receptors after agonist activation is thought to occur either through
clathrin-coated pits or through caveolae. In this study, the role of
these different pathways was investigated in Chinese hamster ovary
cells expressing CCR5 using specific inhibitors. Internalization of
CCR5 after chemokine treatment was inhibited by sucrose, indicating a
role for the clathrin-coated pit pathway. Activation of CCR5 leads to
arrestin-2 movement in the cells, providing further evidence for the
involvement of clathrin-coated pits. Nystatin and filipin also affected
the rate of internalization of CCR5, indicating a role for caveolae.
Using inhibitors of vesicle transport in the cell, it was found that
the CCR5 recycling pathway is independent of the Golgi apparatus and
late endosomes. Protein synthesis is not involved in receptor recovery.
It seems likely that after internalization, CCR5 is directed to early
endosomes and subsequently recycled to the cell surface.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Achour, M. G. H. Scott, H. Shirvani, A. Thuret, G. Bismuth, C. Labbe-Jullie, and S. Marullo
CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surface
Blood,
February 26, 2009;
113(9):
1938 - 1947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yuling, X. Ruijing, J. Xiang, J. Yanping, C. Lang, L. Li, Y. Dingping, T. Xinti, L. Jingyi, T. Zhiqing, et al.
CD19+CD5+ B Cells in Primary IgA Nephropathy
J. Am. Soc. Nephrol.,
November 1, 2008;
19(11):
2130 - 2139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Fernandez, F. Monczor, A. Baldi, C. Davio, and C. Shayo
Histamine H2 Receptor Trafficking: Role of Arrestin, Dynamin, and Clathrin in Histamine H2 Receptor Internalization
Mol. Pharmacol.,
October 1, 2008;
74(4):
1109 - 1118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Cardona, M. Li, L. Liu, C. Savarin, and R. M. Ransohoff
Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation
J. Leukoc. Biol.,
September 1, 2008;
84(3):
587 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bonecchi, E. M. Borroni, A. Anselmo, A. Doni, B. Savino, M. Mirolo, M. Fabbri, V. R. Jala, B. Haribabu, A. Mantovani, et al.
Regulation of D6 chemokine scavenging activity by ligand- and Rab11-dependent surface up-regulation
Blood,
August 1, 2008;
112(3):
493 - 503.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Cardona, M. E. Sasse, L. Liu, S. M. Cardona, M. Mizutani, C. Savarin, T. Hu, and R. M. Ransohoff
Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues
Blood,
July 15, 2008;
112(2):
256 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Meiser, A. Mueller, E. L. Wise, E. M. McDonagh, S. J. Petit, N. Saran, P. C. Clark, T. J. Williams, and J. E. Pease
The Chemokine Receptor CXCR3 Is Degraded following Internalization and Is Replenished at the Cell Surface by De Novo Synthesis of Receptor
J. Immunol.,
May 15, 2008;
180(10):
6713 - 6724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chakera, R. M. Seeber, A. E. John, K. A. Eidne, and D. R. Greaves
The Duffy Antigen/Receptor for Chemokines Exists in an Oligomeric Form in Living Cells and Functionally Antagonizes CCR5 Signaling through Hetero-Oligomerization
Mol. Pharmacol.,
May 1, 2008;
73(5):
1362 - 1370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Delhaye, A. Gravot, D. Ayinde, F. Niedergang, M. Alizon, and A. Brelot
Identification of a Postendocytic Sorting Sequence in CCR5
Mol. Pharmacol.,
December 1, 2007;
72(6):
1497 - 1507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. F. Hamdan, M. D. Rochdi, B. Breton, D. Fessart, D. E. Michaud, P. G. Charest, S. A. Laporte, and M. Bouvier
Unraveling G Protein-coupled Receptor Endocytosis Pathways Using Real-time Monitoring of Agonist-promoted Interaction between beta-Arrestins and AP-2
J. Biol. Chem.,
October 5, 2007;
282(40):
29089 - 29100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pido-Lopez, T. Whittall, Y. Wang, L. A. Bergmeier, K. Babaahmady, M. Singh, and T. Lehner
Stimulation of Cell Surface CCR5 and CD40 Molecules by Their Ligands or by HSP70 Up-Regulates APOBEC3G Expression in CD4+ T Cells and Dendritic Cells
J. Immunol.,
February 1, 2007;
178(3):
1671 - 1679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Soares, R. Foxall, A. Albuquerque, C. Cortesao, M. Garcia, R. M. M. Victorino, and A. E. Sousa
Increased Frequency of Circulating CCR5+ CD4+ T Cells in Human Immunodeficiency Virus Type 2 Infection
J. Virol.,
December 15, 2006;
80(24):
12425 - 12429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Li, C. Luo, M. Mines, J. Zhang, and G.-H. Fan
Chemokine CXCL12 Induces Binding of Ferritin Heavy Chain to the Chemokine Receptor CXCR4, Alters CXCR4 Signaling, and Induces Phosphorylation and Nuclear Translocation of Ferritin Heavy Chain
J. Biol. Chem.,
December 8, 2006;
281(49):
37616 - 37627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Saita, E. Kodama, M. Orita, M. Kondo, T. Miyazaki, K. Sudo, K. Kajiwara, M. Matsuoka, and Y. Shimizu
Structural Basis for the Interaction of CCR5 with a Small Molecule, Functionally Selective CCR5 Agonist.
J. Immunol.,
September 1, 2006;
177(5):
3116 - 3122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Otero, M. Groettrup, and D. F. Legler
Opposite Fate of Endocytosed CCR7 and Its Ligands: Recycling versus Degradation
J. Immunol.,
August 15, 2006;
177(4):
2314 - 2323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Michel, K. Ganter, S. Venzke, J. Bitzegeio, O. T. Fackler, and O. T. Keppler
The Nef Protein of Human Immunodeficiency Virus Is a Broad-Spectrum Modulator of Chemokine Receptor Cell Surface Levels That Acts Independently of Classical Motifs for Receptor Endocytosis and G{alpha}i Signaling
Mol. Biol. Cell,
August 1, 2006;
17(8):
3578 - 3590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Schiavo, D. Baatar, P. Olkhanud, F. E. Indig, N. Restifo, D. Taub, and A. Biragyn
Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses
Blood,
June 15, 2006;
107(12):
4597 - 4605.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pastori, B. Weiser, C. Barassi, C. Uberti-Foppa, S. Ghezzi, R. Longhi, G. Calori, H. Burger, K. Kemal, G. Poli, et al.
Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression
Blood,
June 15, 2006;
107(12):
4825 - 4833.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Thirkill, H. Vedagiri, and G. C. Douglas
Macaque Trophoblast Migration toward RANTES Is Inhibited by Cigarette Smoke-Conditioned Medium
Toxicol. Sci.,
June 1, 2006;
91(2):
557 - 567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. K. Sutherland, R. J. Sanderson, K. A. Gordon, J. Andreyka, C. G. Cerveny, C. Yu, T. S. Lewis, D. L. Meyer, R. F. Zabinski, S. O. Doronina, et al.
Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates
J. Biol. Chem.,
April 14, 2006;
281(15):
10540 - 10547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Christensen, C. de Lemos, T. Moos, J. P. Christensen, and A. R. Thomsen
CXCL10 Is the Key Ligand for CXCR3 on CD8+ Effector T Cells Involved in Immune Surveillance of the Lymphocytic Choriomeningitis Virus-Infected Central Nervous System
J. Immunol.,
April 1, 2006;
176(7):
4235 - 4243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. F. Hamdan, M. Audet, P. Garneau, J. Pelletier, and M. Bouvier
High-Throughput Screening of G Protein-Coupled Receptor Antagonists Using a Bioluminescence Resonance Energy Transfer 1-Based {beta}-Arrestin2 Recruitment Assay
J Biomol Screen,
August 1, 2005;
10(5):
463 - 475.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Barassi, E. Soprana, C. Pastori, R. Longhi, E. Buratti, F. Lillo, C. Marenzi, A. Lazzarin, A. G. Siccardi, and L. Lopalco
Induction of Murine Mucosal CCR5-Reactive Antibodies as an Anti-Human Immunodeficiency Virus Strategy
J. Virol.,
June 1, 2005;
79(11):
6848 - 6858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Signoret, L. Hewlett, S. Wavre, A. Pelchen-Matthews, M. Oppermann, and M. Marsh
Agonist-induced Endocytosis of CC Chemokine Receptor 5 Is Clathrin Dependent
Mol. Biol. Cell,
February 1, 2005;
16(2):
902 - 917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Biragyn, P. A. Ruffini, M. Coscia, L. K. Harvey, S. S. Neelapu, S. Baskar, J.-M. Wang, and L. W. Kwak
Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo
Blood,
October 1, 2004;
104(7):
1961 - 1969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. W. Tawfeek and A. B. Abou-Samra
Important role for the V-type H+-ATPase and the Golgi apparatus in the recycling of PTH/PTHrP receptor
Am J Physiol Endocrinol Metab,
May 1, 2004;
286(5):
E704 - E710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-H. Fan, L. A. Lapierre, J. R. Goldenring, J. Sai, and A. Richmond
Rab11-Family Interacting Protein 2 and Myosin Vb Are Required for CXCR2 Recycling and Receptor-mediated Chemotaxis
Mol. Biol. Cell,
May 1, 2004;
15(5):
2456 - 2469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Ramakrishna, J. F. Treml, L. Vitale, J. E. Connolly, T. O'Neill, P. A. Smith, C. L. Jones, L.-Z. He, J. Goldstein, P. K. Wallace, et al.
Mannose Receptor Targeting of Tumor Antigen pmel17 to Human Dendritic Cells Directs Anti-Melanoma T Cell Responses via Multiple HLA Molecules
J. Immunol.,
March 1, 2004;
172(5):
2845 - 2852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Camina, M. C. Carreira, S. El Messari, C. Llorens-Cortes, R. G. Smith, and F. F. Casanueva
Desensitization and Endocytosis Mechanisms of Ghrelin-Activated Growth Hormone Secretagogue Receptor 1a
Endocrinology,
February 1, 2004;
145(2):
930 - 940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Qiuping, L. Qun, H. Chunsong, Z. Xiaolian, H. Baojun, Y. Mingzhen, L. Chengming, H. Jinshen, G. Qingping, Z. Kejian, et al.
Selectively Increased Expression and Functions of Chemokine Receptor CCR9 on CD4+ T Cells from Patients with T-Cell Lineage Acute Lymphocytic Leukemia
Cancer Res.,
October 1, 2003;
63(19):
6469 - 6477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Venkatesan, J. J. Rose, R. Lodge, P. M. Murphy, and J. F. Foley
Distinct Mechanisms of Agonist-induced Endocytosis for Human Chemokine Receptors CCR5 and CXCR4
Mol. Biol. Cell,
August 1, 2003;
14(8):
3305 - 3324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Huttenrauch, A. Nitzki, F.-T. Lin, S. Honing, and M. Oppermann
beta -Arrestin Binding to CC Chemokine Receptor 5 Requires Multiple C-terminal Receptor Phosphorylation Sites and Involves a Conserved Asp-Arg-Tyr Sequence Motif
J. Biol. Chem.,
August 16, 2002;
277(34):
30769 - 30777.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|